Dengue Test Infectious Disease Rubella Dengue ns1 Diagnostics One Step Antigen Rapid Diagnostics Self Test

Name: Dengue Test Infectious Disease Rubella Dengue ns1 Diagnostics One Step Antigen Rapid Diagnostics Self Test
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 1999274505

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$0.40-0.65

1,000 Pieces

Product profile

Customization

Available

Type

IVD diagnostic kit

Application

Initial screening for rubella infection

Model NO.

101044

OEM

Available

MOQ

1000PCS

Certificate

ISO 13485

Package

25pcs/box or 40pcs/box;

Specimen

WB/S/P

Shelf Life

24 Months

Storage

4-30°c

Format

Cassette

Procedure

Fast and easy to use

Price

Factory supply

Brand

Testsealabs

Product name

Rubella Virus Ab IgG/IgM Test

Transport Package

Carton

Specification

25pcs/box 40pcs/box

Trademark

Testsealabs

Origin

China

Production Capacity

5000000 PCS Per Month

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤11.16h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology is identified as a China-based limited company in Hangzhou, with records describing it as both a trading company and manufacturer/factory. Its stated capabilities include in-vitro diagnostic, veterinary, rapid-test, reagent, and medical-machine products. The supplier reports ISO 9001 and GMP certification, more than 10 production lines, 50 R&D engineers, 50 quality-control staff, and exports to multiple global regions. It describes three technical platforms and sales coverage exceeding 100 countries and regions. However, the evidence does not establish after-sales performance, financial credibility, or product-customization capability. One record associates the supplier with a 2025 THC urine-test product and a Vietnamese buyer, but this is limited customer evidence and does not independently verify broader performance.

Supplier typeThe supplier is identified as a limited company headquartered in Hangzhou, China, and is described as both a trading company/manufacturer-factory. A separate record characterizes the company nature as a factory, supporting a manufacturing role alongside trading activity.

CertificationsThe supplier reports ISO 9001 and GMP certification under its management-system certifications. These are explicit certifications relevant to quality and manufacturing controls.

R&D capabilityThe supplier states that it develops core innovative raw-material technologies and has established immunological detection, molecular-biology detection, and protein core-sheet inspection platforms. The reported 50 R&D engineers and continuing R&D investment further support an established innovation function.

Production capacityThe supplier reports more than 10 production lines, 50 quality-control staff, a one-month off-peak lead time, and broad diagnostic-product offerings. It also reports 90% export sales and access to Shanghai, Ningbo, and Shenzhen ports, although the stated peak-season fulfillment time of 6–12 months indicates substantial seasonal capacity constraints.

Client casesThe supplier states that its products have been sold in more than 100 countries and regions. A separate record identifies a THC urine-test product and one associated Vietnamese buyer, but it does not provide verifiable case details such as order scale, duration, performance results, or references.